We studied the possible association between patient age and sex, clinical presentation, Streptococcus pneumoniae serotype, antimicrobial resistance, and death in invasive pneumococcal disease cases reported by 17 European countries during 2010. The study sample comprised 2,921 patients, of whom 56.8% were men and 38.2% were >65 years of age. Meningitis occurred in 18.5% of cases. Death was reported in 264 (9.0%) cases. Older age, meningitis, and nonsusceptibility to penicillin were significantly associated with death. Non–pneumococcal conjugate vaccine (PCV) serotypes among children 65 years of age, risk did not differ by serotype. These findings highlight differences in case-fatality rates between serotypes and age; thus, continued epidemi...
Differences in pathogenicity between pneumococcal serotypes are important when assessing the potenti...
Streptococcus pneumoniae is a major cause of disease, ranging from uncomplicated respiratory infecti...
International audienceBackground: The long-term benefits of pneumococcal conjugate vaccines (PCVs) r...
We studied the possible association between patient age and sex, clinical presentation, Streptococcu...
We studied the possible association between patient age and sex, clinical presentation, Streptococcu...
We studied the possible association between patient age and sex, clinical presentation, Streptococcu...
International audiencePurpose: Invasive pneumococcal disease (IPD) is responsible for substantial mo...
Background: Pneumococcal disease is a leading cause of morbidity and mortality worldwide. The aim of...
Background: Immunocompromising conditions and advanced age (>= 65 years) are associated with a high ...
OBJECTIVES: The aim of this study was to assess the indirect effect of paediatric 13-valent pneumoco...
Background Implementation of 7-valent pneumococcal conjugate vaccine (PCV7) in the Dutch national im...
Pneumococcal disease is a leading cause of morbidity and mortality worldwide. The aim of this study ...
Differences in pathogenicity between pneumococcal serotypes are important when assessing the potenti...
BACKGROUND In Switzerland, the heptavalent (PCV7) and 13-valent pneumococcal conjugate vaccine (P...
Background: Recently, the 13-valent pneumococcal conjugate vaccine (PCV13) has been recommended for ...
Differences in pathogenicity between pneumococcal serotypes are important when assessing the potenti...
Streptococcus pneumoniae is a major cause of disease, ranging from uncomplicated respiratory infecti...
International audienceBackground: The long-term benefits of pneumococcal conjugate vaccines (PCVs) r...
We studied the possible association between patient age and sex, clinical presentation, Streptococcu...
We studied the possible association between patient age and sex, clinical presentation, Streptococcu...
We studied the possible association between patient age and sex, clinical presentation, Streptococcu...
International audiencePurpose: Invasive pneumococcal disease (IPD) is responsible for substantial mo...
Background: Pneumococcal disease is a leading cause of morbidity and mortality worldwide. The aim of...
Background: Immunocompromising conditions and advanced age (>= 65 years) are associated with a high ...
OBJECTIVES: The aim of this study was to assess the indirect effect of paediatric 13-valent pneumoco...
Background Implementation of 7-valent pneumococcal conjugate vaccine (PCV7) in the Dutch national im...
Pneumococcal disease is a leading cause of morbidity and mortality worldwide. The aim of this study ...
Differences in pathogenicity between pneumococcal serotypes are important when assessing the potenti...
BACKGROUND In Switzerland, the heptavalent (PCV7) and 13-valent pneumococcal conjugate vaccine (P...
Background: Recently, the 13-valent pneumococcal conjugate vaccine (PCV13) has been recommended for ...
Differences in pathogenicity between pneumococcal serotypes are important when assessing the potenti...
Streptococcus pneumoniae is a major cause of disease, ranging from uncomplicated respiratory infecti...
International audienceBackground: The long-term benefits of pneumococcal conjugate vaccines (PCVs) r...